Announcements and exhibition information will be released periodically.
Dalong Biotech Annual Staff Trip Concludes Successfully | Team Returns Energized to Deliver Premium Service
Dalong Biotech Annual Staff Trip Concludes Successfully | Team Returns Energized to Deliver Premium Service
Dalong Biotech held its annual staff trip from June 14 to June 19, treating the entire team to a rejuvenating journey through central Vietnam. From the UNESCO-listed Ancient Town of Hội An to the iconic Golden Bridge atop Bà Nà Hills, the team has now returned to their posts, fully recharged and ready to serve.
2026 / 06
22
Dalong Biotech Brings Professional Expertise to Healthcare | Weight Management Product Training at Dr. Chen’s ENT Clinic, Hsinchu
Dalong Biotech Brings Professional Expertise to Healthcare | Weight Management Product Training at Dr. Chen’s ENT Clinic, Hsinchu
Dalong Biotech was recently invited to Dr. Chen Zhi-Cheng’s ENT Clinic in Hsinchu to conduct a professional weight management product training session for the clinic’s medical team. Through in-depth scientific presentations and practical sharing, Dalong Biotech aims to translate evidence-based nutritional solutions into a shared commitment to supporting patients’ body composition and overall health.
2026 / 06
03
Deepening Southeast Asia Market Presence: Dalong Biotech Hosts Malaysian Business Delegation, Opening New Avenues for International Partnership
Deepening Southeast Asia Market Presence: Dalong Biotech Hosts Malaysian Business Delegation, Opening New Avenues for International Partnership
Dalong Biotech recently welcomed a business delegation composed of representatives from Changchun Pao Biotech and Malaysian partner companies. Discussions covered Malaysian market trends, product and technology exchange, and the international expansion potential of Dalong’s own brand “NUMA” — laying a solid foundation for future cross-border collaboration in the functional health supplement sector.
2026 / 04
27
Dalong Biotech’s Cordyceps militaris Sleep Health R&D Project Approved by Taiwan’s MOEA CITD Program
Dalong Biotech’s Cordyceps militaris Sleep Health R&D Project Approved by Taiwan’s MOEA CITD Program
Dalong Biotech’s R&D capabilities reach a new milestone. Our proprietary Biphasic Immobilization Dual-Stage Fermentation Technology has been approved under the FY2026 CITD program, enabling Cordyceps militaris to naturally synthesize key bioactives including GABA and cordycepin. This native multi-compound synergistic system offers a science-backed, natural approach to restoring healthy sleep rhythms — a safer, gentler alternative for modern consumers seeking long-term sleep quality support.
2026 / 04
22